Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down – Here’s Why

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $8.89, but opened at $8.48. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.51, with a volume of 3,794 shares.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The firm has a market capitalization of $14.50 billion, a P/E ratio of 13.32, a P/E/G ratio of 2.02 and a beta of 0.19. The stock’s fifty day simple moving average is $8.38 and its 200 day simple moving average is $8.56. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.44 and a quick ratio of 5.74.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings results on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. The business had revenue of $740.85 million for the quarter, compared to analysts’ expectations of $742.35 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. On average, equities research analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.